2023 | Targeting AXL Using the AVB-500 Soluble Receptor and through Genetic Knockdown Inhibits Bile Duct Cancer Growth and Metastasis
| CANCERS |
2013 | Telomerase- and angiogenesis-related gene responses to irradiation in human umbilical vein endothelial cells | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE |
2010 | The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up | ANNALS OF SURGICAL ONCOLOGY |
2010 | The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
2014 | The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. | MOLECULAR CANCER THERAPEUTICS |
2019 | The Effect of Nutrition Intervention with Oral Nutritional Supplements on Pancreatic and Bile Duct Cancer Patients Undergoing Chemotherapy
| NUTRIENTS |
2022 | The UGT1A9*22 genotype identifies a high-risk group for irinotecan toxicity among gastric cancer patients
| Genomics & Informatics |
2005 | Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents | BIOCHEMICAL PHARMACOLOGY |
2023 | Trastuzumab Combined With Ramucirumab and Paclitaxel in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Advanced Gastric or Gastroesophageal Junction Cancer | JOURNAL OF CLINICAL ONCOLOGY |
2002 | Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy. | BRITISH JOURNAL OF SURGERY |
2010 | Two dosages of oral fluoropyrimidine S-1 of 35 and 40 mg/m2 bid: comparison of the pharmacokinetic profiles in Korean patients with advanced gastric cancer
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY |
2008 | Variation of the 3' telomeric overhang lengths in human cells | CANCER LETTERS |
2010 | Wernicke's encephalopathy in advanced gastric cancer
| CANCER RESEARCH AND TREATMENT |
2007 | Whole genome analysis for liver metastasis gene signatures in colorectal cancer | INTERNATIONAL JOURNAL OF CANCER |
2004 | 공존이환(comorbidity)이 있는 암환자에서의 항암약물치료
| Journal of the Korean Gastric Cancer Association (대한위암학회지) |
1997 | 생물학적 치료 목표로서 위암에서 Midkine 발현의 탐색 | Journal of the Korean Cancer Association (대한암학회지) |
1997 | 위암 진행 표지자로서 혈액내 Intercellular Adhesion Molecule-1 (ICAM-1)과 Vascular Cell Adhesion Molecule-1 (VCAM-1)의 동시 발현 | Journal of the Korean Cancer Association (대한암학회지) |
2000 | 위암에서 ex vivo Model 을 이용한 MMP - 9 에 대한 Gabexate Mesylate IC50의 응용 : 예후인자 및 치료대상 선정기준
| Journal of the Korean Cancer Association (대한암학회지) |
2000 | 유방암 조직에서 Urokinase - type Plasrninogen Activator Receptor 발현의 임상적 의의
| Journal of the Korean Cancer Association (대한암학회지) |
2006 | 유방암의 전신적 재발로 오인된 톡소플라스마증 1예
| Korean Journal of Medicine |
2010 | 폐전이를 동반한 성문 하에서 발생한 선양낭성암종 1예
| Korean Journal of Bronchoesophagology (대한기관식도과학회지) |